Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05216_nanopub.RAMf9HSt6Bf2vr5Q_U4i1hUYf8RqsDq5zFP_xhmUmoJe4#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05216 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05216 label "MP470 [drugbank:DB05216]" assertion.
- drugbank:DB05216 seeAlso DB05216 assertion.
- drugbank:DB05216 description "MP470 is an oral, selective multi-targeted tyrosine kinase inhibitor that suppresses c-MET, c-RET and the mutant forms of c-KIT, PDGFR and FLT3. MP470 also suppresses Rad51 protein, a critical component of double-stranded DNA repair in cancer cells. Preclinical testing of MP470 has identified anti-tumor activity against a wide spectrum of cancers." assertion.
- drugbank:DB05216 identifier "drugbank:DB05216" assertion.
- drugbank:DB05216 title "MP470" assertion.
- drugbank:DB05216 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05216 drugbank_vocabulary:drugbank-id "DB05216" assertion.
- drugbank:DB05216 bio2rdf_vocabulary:x-identifiers.org DB05216 assertion.
- drugbank:DB05216 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05216" assertion.
- drugbank:DB05216 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05216 bio2rdf_vocabulary:identifier "DB05216" assertion.